Why the study?
Inflammation plays an important role in cardiogenic shock pathogenesis, but whether the neutrophil-lymphocyte ratio is associated with outcomes in these patients remains unknown.
Is the neutrophil-lymphocyte ratio (NLR) associated with 30-day mortality in patients with cardiogenic shock?
Is the neutrophil-lymphocyte ratio (NLR) associated with 30-day mortality in patients with cardiogenic shock?
An intermediate elevation of the neutrophil-lymphocyte ratio (9.4-15) is associated with the highest risk of 30-day mortality in patients with cardiogenic shock, demonstrating an inverse U-shaped relationship.
NLR may flag higher-risk CGS patients but should not yet change practice; leaves open added value over SOFA.
BACKGROUND Inflammation plays an important part in the pathogenesis of cardiogenic shock (CGS). Whether the neutrophil-lymphocyte ratio (NLR), an integrated biomarker of inflammation, is associated with the outcome of CGS patients remains unknown. This retrospective cohort study was performed to identify the utility of using NLR among patients with CGS. MATERIAL AND METHODS Data were extracted from the MIMIC database. We applied smooth curve fitting to define the NLR cutoff values. The primary outcome was 30-day mortality. Cox proportional hazards models, subgroup analysis, and receiver operator characteristic (ROC) curve analysis were performed. RESULTS A total of 1470 CGS patients were extracted, among which 801 (54.5%) were men. The mean age of the population was 70.37 years. An inverse U-shaped relationship was observed between NLR and mortality in CGS patients, with the highest risk being at values ranging from 9.4 to 15. For the primary outcome of 30-day mortality, the adjusted HR (95% CI) values of the middle tertile (NLR 9.4-15) and the upper tertile (NLR >15) were 1.47 (1.14, 1.88) and 1.22 (0.94, 1.57) compared with the reference of lower tertile (NLR <9.4). ROC curve analysis showed that NLR had a more sensitive prognostic value in predicting 30-day mortality of CGS than the neutrophil or lymphocyte percentage alone (0.660 vs. 0.540, 0.549). CONCLUSIONS An inverse U-shaped curve was presented between NLR and the mortality of CGS. NLR seemed to be a readily available and independent prognostic biomarker for patients with CGS. The prognostic value of NLR was more sensitive than the neutrophil or lymphocyte percentage alone, but not as good as SOFA or SAPSII score.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: